All
RSSArticles
-
Exercising After Cancer: Newest Evidence-Based Guidelines
The 2018 guidelines for exercise in cancer survivors conclude there is sufficient evidence to recommend specific doses of aerobic exercise, resistance training, and/or a combination of the two to improve common symptoms found in this population, such as anxiety, depression, fatigue, and quality of life.
-
Expansion and Versatility of Telemedicine During the COVID-19 Pandemic
Telemedicine has rapidly transformed healthcare delivery during the COVID-19 pandemic, but innovative reimbursement models and updated privacy regulations are needed to ensure widespread implementation of high-quality digital care.
-
Two Possible Mechanisms of Disease in COVID-19
COVID-19 infection may be associated with an increased risk of blood clotting and related thrombotic events, but there are insufficient data to support indiscriminately discontinuing medications that play a critical role in the management of chronic cardiovascular disease.
-
Intermittent Fasting for Weight Loss: Hope or Hype?
This article explores the existing evidence for using intermittent fasting as a strategy to promote weight loss. The evidence suggests that intermittent fasting worked as well as continuous energy restriction to achieve weight loss, but was not superior.
-
Guillain-Barré, Miller Fisher Syndrome, and Associated Disorders in Patients with COVID-19
As the COVID-19 pandemic spreads around the world, investigators in multiple countries are reporting patients with myriad cranial and peripheral nerve disorders that have some, but not all, features of Guillain-Barré syndrome.
-
The Effect of Coronaviruses on the Central Nervous System
Known coronaviruses can enter the central nervous system by different pathophysiologic mechanisms. Neurological presentations linked to the novel SARS-CoV-2 include encephalopathy, encephalitis, cranial neuropathies, Guillain-Barré syndrome and other neuropathies, and ischemic and hemorrhagic strokes.
-
Neurologic Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China
Neurological symptoms and impairments have been found in one-third of hospitalized patients with COVID-19 from countries that have reported these observations so far. This is a rapidly evolving consequence of SARS-CoV-2 infection.
-
Epilepsy Management
Epilepsy affects about 50 million people worldwide and is responsible for up to 0.5% of the global burden of disease. Although many people learn to handle their epilepsy at home, patients often are brought to the emergency department if they have a seizure in public or it is their first seizure.
-
Research Organizations Face Challenges New and Old
As current studies resume and new studies are approved, IRBs and researchers should keep basic safety and regulatory practices in mind, according to experts on the front lines of human research protection and clinical trials.
-
Q&A Part 3: IRBs Learn Positive and Instructional Lessons from Pandemic
IRB experts share the ways in which the pandemic has spurred innovation in their institutions.